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Objective: Recent data suggest the involvement of dectin-1 in atherosclerosis through regulation of local
reactive oxygen species production. The aim of the current study was to assess the effect of dectin-1
deﬁciency on atherosclerotic plaque development.
Methods: Using immunohistochemistry dectin-1 expression was observed on foamy macrophages in
atherosclerotic lesions in mice. Following lethal irradiation LDLR/ mice were reconstituted with bone
marrow from either wild type or dectin-1/ mice. After recovery, mice were fed a high fat diet for 9
weeks and atherosclerotic lesions were analyzed.
Results and conclusion: Overall, we found no signiﬁcant differences in plaque size or severity between the
groups. Also no differences were observed in granulocyte or macrophage composition of the plaques or
in the ability to produce reactive oxygen species by macrophages from both groups. Dectin-1 is
dispensable for the development of atherosclerotic lesions in mice.
© 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Atherosclerosis is a chronic inﬂammatory disease of the vessel
wall [1]. Hyperlipidemia triggers an inﬂammatory response leading
to the recruitment of circulating monocytes, which subsequently
differentiate into macrophages. These macrophages scavenge
modiﬁed lipids and mediate local production of cytokines, chemo-
kines and reactive oxygen species (ROS) resulting in foam cell for-
mation and increasing vascular inﬂammation [2]. Macrophages
express a rangeof surface pattern recognition receptors that serve as
sensors for exogenous pathogen-associated molecular patterns and
endogenousdamage-associatedmolecular patterns [3].Dectin-1 is a
well-characterized receptor for b-glucans on macrophages and itResearch, Sanquin Research
1066CX Amsterdam, The
.
scribed in this study.
rved.plays a critical role in thehost defense against fungi [4]. Recently, the
intracellular ﬁlament protein vimentin was reported to function as
an endogenous ligand for dectin-1 [5]. In vitro studies showed that
binding of vimentin, which is released from macrophages upon in-
ﬂammatory stimulation [6], can trigger the production of ROS [5]
and this might further promote the atherogenic process. The pres-
ence of vimentin inhumanatherosclerotic lesions in close proximity
to dectin-1 positive macrophages was also demonstrated, suggest-
ing a possible involvement of the vimentin-dectin-1 axis in the
pathogenesis of atherosclerosis [5].
Here, we have directly addressed the involvement of dectin-1 in
the development of atherosclerosis. While our ﬁndings conﬁrm a
distinctive expression of dectin-1 on macrophages in mouse
atherosclerotic lesions, we do not ﬁnd any detectable effect of
dectin-1-deﬁciency on atherosclerotic plaque formation in mice.2. Material and methods
Bone-marrow transplantation of wild type (wt) and dectin-1/
K. Szilagyi et al. / Atherosclerosis 239 (2015) 318e321 319cells into LDLR/ mice (all on C57Bl/6 background) were per-
formed and the development of atherosclerosis was evaluated.
Details of all experimental procedures can be found in online-only
supplementary data.
3. Experimental results
3.1. Macrophages in mouse atherosclerotic lesions express dectin-1
Atherosclerotic lesions in LDLR/ mice, at different stages of
development, were stained for dectin-1 to study its expression
pattern during lesion formation. As shown in Fig. 1, mouse
atherosclerotic lesions show high expression of dectin-1 colocal-
izing with the macrophage speciﬁc marker MOMA-2. Dectin-1Fig. 1. Plaque macrophages in mice express dectin-1 at all stages of development. Mouse a
marker and with a-dectin-1 antibody at different stages of development: A ¼ early lesion; B
(unstable phenotype) with a small necrotic core (D) and a large necrotic core (E). First two impositive macrophages were identiﬁed at all stages of lesion devel-
opment. Particularly in early lesions, dectin-1 showed a complete
overlap with MOMA-2 (Fig. 1AeC), whereas in more advanced le-
sions not all MOMA-2 positive macrophages appeared to show
expression of dectin-1 (Fig. 1DeE). These ﬁndings are in line with
previous reports demonstrating dectin-1 on subsets of macro-
phages in human atherosclerotic lesions [5,7].
3.2. Mice lacking dectin-1 show normal atherosclerosis
development
In order to investigate the functional role of dectin-1 in
atherosclerosis we next reconstituted LDLR/ mice with bone
marrow from wild-type or dectin-1 deﬁcient mice [8] and studiedtherosclerotic lesions were stained for macrophages using MOMA-2 as a macrophage
¼moderate lesion; C ¼ advanced lesion (stable phenotype); D and E ¼ advanced lesion
ages in each row show 10magniﬁcation, second two images show 20magniﬁcation.
Fig. 2. Chimeric LDLR/ mice lacking dectin-1 have normal atherosclerotic lesions. Upon irradiation bone marrow of LDLR/ mice was replaced with wt cells or cells lacking
dectin-1. After recovery the mice were fed for a period of 9 weeks with a high fat diet to develop atherosclerosis. A The size of lesions quantiﬁed after toluidine blue staining was
comparable between wt->LDLR/ and dectin-1/->LDLR/mice. Images below the graph show dectin-1 staining of lesions conﬁrming absence of dectin-1 staining in dectin-1/
->LDLR/mice. B Dectin-1 chimeras show slightly increased severity of plaques with more advanced lesions (Chi-square test, p ¼ 0.051). C Composition of atherosclerotic lesions
in wt and dectin-1/ chimeras shows no differences. D Numbers of granulocytes and E macrophage area are similar in wt->LDLR/ and dectin-1/->LDLR/ mice. F Ability of
mouse M-CSF cultured BMDM to produce ROS after stimulation with serum-treated zymosan (stz), zymosan (zym) and vimentin was tested using Amplex red assay as described in
Materials and Methods section. Differences were tested by T-test in Figures A, C, D, E and F. In the Figure B Chi-square test was used. P value <0.05 was considered signiﬁcant.
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The animals showed no differences in their weight, blood levels of
cholesterol and triglycerides, or circulating leukocytes
(Supplementary Figure I). After 9 weeks of high fat diet, the
atherosclerotic plaques were analyzed for size, severity andcomposition. The size of the lesion areas of dectin-1/ chimeras
were identical to that in the wt transplants (Fig. 2A). In addition,
plaques of dectin-1/ mice showed only a trend towards a more
severe phenotype compared to wt animals, but this did not reach
statistical signiﬁcance (Fig. 2B). Also the composition of the
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 and wt chimeras (Fig. 2C). Furthermore, quantiﬁcation of the
numbers of granulocytes in lesions and the surface area of the
plaques occupied by macrophages also excluded a detectable role
of dectin-1 in leukocyte inﬁltration into the lesions (Fig. 2D and E).
Collectively, these data argue against a notable role for dectin-1 in
atherosclerosis development.
3.3. Vimentin fails to induce respiratory burst in mouse
macrophages
Using human monocytes the intermediate ﬁlament protein
vimentin, which can be secreted upon activation [6], was recently
identiﬁed as a potential endogenous ligand for dectin-1 inducing
production of ROS [5]. We tested whether the same holds true for
mouse macrophages. It was previously shown that bone marrow-
derived macrophages (BMDM) express dectin-1 [4] and therefore
we used them as a model to test induction of respiratory burst by
vimentin. We used BMDM of wt and dectin-1/ mice and stimu-
lated them with vimentin or other stimuli known to induce ROS
production. As shown in Fig. 2F, BMDM of both wt and dectin-1/
mice responded to zymosan and serum-treated zymosan, with
lower response to zymosan as previously reported [8]. However,
the macrophages failed to produce ROS when stimulated with
vimentin (Fig. 2F), and the same was found when 10-fold higher
concentrations of vimentin were used (data not shown). It should
be noted that we could not reproduce the effect of vimentin on ROS
production by freshly isolated human monocytes as described
before [5] (Supplementary Figure II). Moreover, we detected pres-
ence of vimentin in lesions of wt and dectin-1/ chimeras
(Supplementary Figure III) excluding a possibility that there is lack
of this dectin-1 ligand in a mouse model.
4. Discussion
Our present results show that C-type lectin receptor (CLR)
dectin-1 is essentially dispensable for development of atheroscle-
rosis in an in vivo mouse model. Dectin-1 is a major pattern
recognition receptor on myeloid cells [4] where it regulates im-
mune responses towards fungal pathogens [8]. To address the
question how dectin-1 on myeloid cells contributes to develop-
ment of atherosclerosis we chose to perform bone marrow trans-
plantation of wt and dectin-1/ into LDLR/ to exclude any
possible effect of dectin-1 signaling in non-hematopoietic tissues,
although the expression of dectin-1 is very low in non-immune
cells [9]. Mice lacking dectin-1 in the hematopoietic compart-
ment have normal size and composition of the plaques when
compared towt bonemarrowchimeras. Although therewas a trend
towards somewhat more severe atherosclerotic lesions in the
dectin-1/ chimeras, the overall ﬁndings argue against a signiﬁ-
cant role for dectin-1 in atherosclerotic plaque development.
Clearly, our current ﬁndings do not support the recent hypoth-
esis that dectin-1 would, through interactionwith the intermediate
ﬁlament protein vimentin, play a role in atherogenesis, as was
suggested by the identiﬁcation of both dectin-1 and vimentin in
human atherosclerotic lesions and the dectin-1-dependentvimentin-induced ROS production by human monocytes [5].
Our observations also argue against a role for vimentin-induced
ROS production through dectin-1 [5]. In particular, we were unable
to reproduce the stimulatory effect of recombinant vimentin on
ROS production by murine macrophages. Whether this apparent
discrepancy is due to species differences in the vimentin or dectin-
1 used, or to a more trivial explanation, such as a (microbial)
contamination in the original vimentin preparation [5], is not clear
at present. It should also be noted that the role of vimentin as a pro-
inﬂammatory mediator has been recently questioned [10].
In summary, it appears that dectin-1 is dispensable for the
development of atherosclerosis in vivo, at least in the mouse
experimental system that we have investigated here.
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